The emergence of blockchain technology is regarded as 4th industrial revolution i.e., the integration of cyber-physical systems since the advent of Internet with far reaching applications in Banking, Insurance and Government, may impact other sectors especially life sciences. The fourth revolution is characterized by fusion of technologies that is blurring the lines between the physical, digital, and biological spheres. Therefore, it is vital to understand the opportunities and threats of adopting this technology in life science/pharmaceutical research. The proprietary databases of today's institutions interact with some form of interface either human or otherwise. Integrating blockchain with life science/pharmaceutical applications will decentralize the interface as well as the data exchange, resulting in high efficiency, greater speeds, low marginal cost, and infinite scalability. [ABSTRACT FROM AUTHOR]